5 May 2026

Life Sciences Patent Network Awards 2026

Published by Newton Media
DLA Piper has won "Excellence in Patent Licensing and Transactions" and been named highly commended in "Medical Device IP Firm of the Year Award" by the Life Sciences Patent Network (LSPN) Awards 2026. LSPN recognizes excellence, innovation, and leadership in life sciences IP.
Read more
Contributors:Erin GibsonMatthew SatchwellLarissa BifanoRaymond MillerLisa HaileNicole EndejannLauren Murdza

Related news

News

DLA Piper advises Everstone Capital on US$270 million investment in Apothecon Group

20 April 2026

News
Lab table

DLA Piper advises Alfasigma on US$690 million global licensing deal for rare disease...

11 March 2026

News

DLA Piper advises Aspen Neuroscience in Series C financing aimed at advancing personalized...

24 November 2025

Related capabilities

Life SciencesIntellectual Property

Contact our media team